Page last updated: 2024-11-11

hexahydroubiquinone-4

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6436802
SCHEMBL ID11670953
MeSH IDM0041484

Synonyms (19)

Synonym
hexahydroubiquinone-4
2,3-dimethoxy-5-methyl-6-[(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enyl]cyclohexa-2,5-diene-1,4-dione
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15-tetramethyl-2-hexadecenyl)-, (r-(r*,r*-(e)))-
nsc 226994
SCHEMBL11670953
2,3-dimethoxy-5-methyl-6-[(2e,7r,11r)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]-2,5-cyclohexadiene-1,4-dione
DTXSID201110010
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,7r,11r)-3,7,11,15-tetramethyl-2-hexadecenyl)-
phytylubiquinone
DRE9U9K7QB
phytylubiquinone, trans-
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,7r,11r)-3,7,11,15-tetramethyl-2-hexadecen-1-yl)-
hexahydroubiquinone q4
trans-phytylubiquinone
hexahydroubiquinone 4
koq4
ubiquinone 4, hexahydro-
coenzyme q4, hexahydro-
p-benzoquinone, 2,3-dimethoxy-5-methyl-6-phytyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]